Exclusions were made for 28 participants with outlier values in liver function parameters (AST above 63, ALT above 62, ALP above 189, total bilirubin above 1.7, and albumin below 2.8), four with hepatocellular carcinoma, and six with liver cirrhosis. This evidence concerns the gene ALB and hepatocellular carcinoma.